Guidelines for diagnostics and treatment of aromatase inhibitor‐induced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians181. This evidence concerns the gene CYP19A1 and breast carcinoma.